Literature DB >> 20034599

Contribution of the intra-specimen variations in tissue mineralization to PTH- and raloxifene-induced changes in stiffness of rat vertebrae.

Sarah K Easley1, Michael G Jekir, Andrew J Burghardt, Mei Li, Tony M Keaveny.   

Abstract

The intra-specimen spatial variation in mineralization of bone tissue can be changed by drug treatments that alter bone remodeling. However, the contribution of such changes to the overall biomechanical effect of a treatment on bone strength is not known. To provide insight into this issue, we used a rat model to determine the effects of ovariectomy, parathyroid hormone, and raloxifene (vs. sham) on the contribution of spatial variations in mineralization to treatment-induced changes in vertebral stiffness. Mineral density was measured from 6-microm voxel-sized quantitative micro-CT scans. Whole-vertebral and trabecular stiffness values were estimated using finite element analysis of these micro-CT scans, first including all intra-specimen variations in mineral density in the model and then excluding such variations by using a specimen-specific average density throughout each specimen. As expected, we found appreciable effects of treatment on overall bone stiffness, the effect being greater for the trabecular compartment (up to 52% reduction vs. sham, p<0.0001) than the whole vertebra (p=0.055). Intra-specimen mean mineralization was not changed with treatment but the intra-specimen variation in mineralization was, although the effect was small (4%). Intra-specimen spatial variations in mineralization accounted for 10-12% and 5-6% of overall stiffness of the trabecular compartment and whole vertebral body, respectively. However, after accounting for all treatment effects on bone geometry and trabecular microstructure, any treatment effects due to changes in mineralization were negligible (<2%), although statistically detectable (p<0.02). We conclude that, despite a role in the general biomechanical behavior of bone, the spatial variations in tissue mineralization, as measured by quantitative micro-CT, did not appreciably contribute to ovariectomy-, PTH-, or raloxifene-induced changes in stiffness of the whole bone or the trabecular compartment in these rat vertebrae. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20034599     DOI: 10.1016/j.bone.2009.12.009

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  13 in total

1.  Biaxial normal strength behavior in the axial-transverse plane for human trabecular bone--effects of bone volume fraction, microarchitecture, and anisotropy.

Authors:  Arnav Sanyal; Tony M Keaveny
Journal:  J Biomech Eng       Date:  2013-12       Impact factor: 2.097

2.  Predicting mouse vertebra strength with micro-computed tomography-derived finite element analysis.

Authors:  Jeffry S Nyman; Sasidhar Uppuganti; Alexander J Makowski; Barbara J Rowland; Alyssa R Merkel; Julie A Sterling; Todd L Bredbenner; Daniel S Perrien
Journal:  Bonekey Rep       Date:  2015-04-22

3.  A novel technique with reduced computed tomography exposure to predict vertebral compression fracture: a finite element study based on rat vertebrae.

Authors:  Giovanni F Solitro; Florian Mainnemare; Farid Amirouche; Ankit Mehta
Journal:  Med Biol Eng Comput       Date:  2018-11-07       Impact factor: 2.602

4.  Effect of intraspecimen spatial variation in tissue mineral density on the apparent stiffness of trabecular bone.

Authors:  Narges Kaynia; Elaine Soohoo; Tony M Keaveny; Galateia J Kazakia
Journal:  J Biomech Eng       Date:  2015-01       Impact factor: 2.097

5.  Theoretical bounds for the influence of tissue-level ductility on the apparent-level strength of human trabecular bone.

Authors:  Shashank Nawathe; Frédéric Juillard; Tony M Keaveny
Journal:  J Biomech       Date:  2013-03-14       Impact factor: 2.712

6.  Age-related changes in the fracture resistance of male Fischer F344 rat bone.

Authors:  Sasidhar Uppuganti; Mathilde Granke; Alexander J Makowski; Mark D Does; Jeffry S Nyman
Journal:  Bone       Date:  2015-11-22       Impact factor: 4.398

7.  The BALB/c mouse as a preclinical model of the age-related deterioration in the lumbar vertebra.

Authors:  Dominique Harris; Kate Garrett; Sasidhar Uppuganti; Amy Creecy; Jeffry S Nyman
Journal:  Bone       Date:  2020-05-29       Impact factor: 4.398

8.  Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.

Authors:  Jeffry S Nyman; Alyssa R Merkel; Sasidhar Uppuganti; Bijaya Nayak; Barbara Rowland; Alexander J Makowski; Babatunde O Oyajobi; Julie A Sterling
Journal:  Bone       Date:  2016-07-14       Impact factor: 4.398

9.  Age Dependence of Systemic Bone Loss and Recovery Following Femur Fracture in Mice.

Authors:  Armaun J Emami; Chrisoula A Toupadakis; Stephanie M Telek; David P Fyhrie; Clare E Yellowley; Blaine A Christiansen
Journal:  J Bone Miner Res       Date:  2018-09-24       Impact factor: 6.741

10.  Research perspectives: The 2013 AAOS/ORS research symposium on Bone Quality and Fracture Prevention.

Authors:  Eve Donnelly; Joseph M Lane; Adele L Boskey
Journal:  J Orthop Res       Date:  2014-04-02       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.